VIVS VivoSim Labs, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 12, 2026
$0,20
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,1952 haftanın en düşüğü
$3,5452 haftanın en yükseği
Piyasa Değeri (MRQ)
$627.4K
P/E (TTM)
-0.0
Hisse Başına Kâr (TTM)
$-4.46
Gelir (TTM)
$112.0K
rozetleriniz
52 Haftlık Aralık
$0–$4
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
·
P/E
-0.0
ROE
-343.1%
Net Kâr Marjı
-11016.1%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
VIVS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.20
Piyasa Değeri (MRQ)
$627.4K
P/E (TTM)
-0.0
Hisse Başına Kâr (TTM)
$-4.46
Gelir (TTM)
$112.0K
ROE (TTM)
-343.1%
52 Haftlık Aralık
$0–$4
VIVS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 21 Mart 2025 | 1-for-12 | Ters |
| 19 Ağustos 2020 | 1-for-20 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$131.0K2017-03-31 → 2026-03-31
Hisse Başına Kâr$-5.352022-03-31 → 2026-03-31
Serbest Nakit Akışı$-11M2017-03-31 → 2026-03-31
Net kar marjı-11016.1%2017-03-31 → 2026-03-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | VIVS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -0.05Y ort. ≈-9.9 | ≈-9.9 | · | · | |
| F/S (TTM) | 5.6 | · | 4.6 | Aşırı değerli | |
| F/D (MRQ) | -0.3 | · | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -0.1 | · | · | · | |
| Fiyat / Nakit Akışı (TTM) | -0.1 | · | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.15Y ort. ≈15.7 | ≈15.7 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | VIVS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -10117.0% | · | -1012.6% | Zayıf | |
| FAVÖK Marjı (TTM) | -9943.8% | · | -1011.2% | Zayıf | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | -10565.6% | · | -5290.5% | Zayıf | |
| Net Kâr Marjı (TTM) | -11016.1% | · | -952.6% | Zayıf | |
| ROA (TTM) | -155.9% | · | -121.4% | Zayıf | |
| ROE (TTM) | -343.1% | · | -294.8% | Aynı seviyede | |
| ROIC | 1045.4% | · | -113.3% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | VIVS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 1.7 | · | 2.1 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 1.8 | · | 1.8 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | VIVS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -9.0%5Y ort. ≈-30.7% | ≈-30.7% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -29.3% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | VIVS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.0 | · | 0.0 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 4.2 | · | 4.6 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$8.7K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-183.7%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 31 Mart 2025 | $-2.21 | $-0.19 | -1040.4% | |
| 31 Aralık 2024 | $-2.29 | $-2.57 | 10.8% | |
| 30 Eylül 2024 | $-1.68 | $-3.18 | 47.2% | |
| 30 Haziran 2024 | $-2.76 | $-4.04 | 31.7% | |
| 31 Mart 2024 | $-3.48 | $-5.14 | 32.3% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $131.0K | $144.0K | $109.0K | $370.0K | $2M | $0 | $2M | $3M | $5M | $4M | $1M | $571.0K | |
| Cost of Revenue | $0 | $5.0K | · | · | · | $0 | $328.0K | $482.0K | $1M | $956.0K | $0 | $0 | |
| R&D Expense | $4M | $5M | $5M | $9M | $3M | $1M | $5M | $15M | $18M | $20M | $18M | $13M | |
| SG&A Expense | $7M | $8M | $10M | $9M | $10M | $16M | $18M | $15M | $21M | $22M | $22M | $18M | |
| Operating Expenses | $12M | $13M | $15M | $18M | $13M | $17M | $24M | $30M | $40M | $43M | $40M | $31M | |
| Operating Income | $-11M | $-13M | $-15M | $-18M | $-11M | $-17M | $-21M | $-27M | $-35M | $-39M | $-39M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | $0 | $1.0K | |
| Interest Income | $267.0K | $140.0K | $405.0K | $454.0K | $8.0K | $15.0K | $594.0K | $705.0K | $478.0K | $198.0K | $88.0K | $32.0K | |
| Other Non-op | $-2M | $10M | $417.0K | $474.0K | $25.0K | $6.0K | $2M | $0 | $-12.0K | $0 | $0 | $215.0K | |
| Pretax Income | $-14M | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $3.0K | $2.0K | $23.0K | $3.0K | $0 | |
| Net Income | $-14M | $-2M | $-15M | $-17M | $-11M | $-17M | $-19M | $-27M | $-35M | $-38M | $-39M | $-30M | |
| EPS (Basic) | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 | · | · | · | · | · | · | · | |
| Shares (Basic) | 2,588,327 | 1,463,609 | 762,076 | 8,713,032 | 8,703,596 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 2,588,327 | 1,463,609 | 762,076 | 8,713,032 | 8,703,596 | · | · | · | · | · | · | · | |
| EBITDA | $-11M | · | · | · | $-11M | · | · | $-26M | $-34M | $-37M | $-38M | $-30M |
Bilanço
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $11M | $3M | $15M | $29M | $37M | $27M | $36M | $44M | $63M | $62M | $50M | |
| Short-term Investments | · | · | · | · | $0 | · | · | · | · | · | · | · | |
| Receivables | $32.0K | $30.0K | $33.0K | $152.0K | $0 | $0 | $111.0K | $503.0K | $883.0K | $647.0K | $259.0K | $0 | |
| Inventory | · | $0 | $297.0K | $0 | · | · | $0 | $490.0K | $842.0K | $550.0K | $334.0K | $66.0K | |
| Prepaid Expense | $557.0K | $789.0K | $705.0K | $889.0K | $858.0K | $1M | $851.0K | $1M | $1M | $1M | $968.0K | $1M | |
| Other Current Assets | $0 | $12.0K | $4.0K | $69.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $7M | $12M | $4M | $17M | $30M | $38M | $28M | $39M | $47M | $65M | $64M | $51M | |
| PP&E (Net) | $206.0K | $419.0K | $669.0K | $902.0K | $662.0K | $381.0K | $0 | $2M | $3M | $4M | $4M | $2M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $1M | $415.0K | $6M | $7M | $7M | $6M | $3M | |
| Accum. Depreciation | $2M | $2M | $1M | $1M | $1M | $1M | $415.0K | $5M | $4M | $3M | $2M | $1M | |
| Other Non-current Assets | · | · | · | · | · | $1M | $123.0K | $138.0K | $152.0K | $121.0K | $134.0K | $106.0K | |
| Total Assets | $7M | $15M | $6M | $20M | $33M | $40M | $28M | $41M | $50M | $69M | $68M | $53M | |
| Accounts Payable | $1M | $2M | $627.0K | $331.0K | $415.0K | $281.0K | $720.0K | $628.0K | $464.0K | $1M | $787.0K | $1M | |
| Accrued Liabilities | $981.0K | $1M | $727.0K | $3M | $489.0K | $440.0K | $1M | $3M | $3M | $4M | $2M | $2M | |
| Current Liabilities | $3M | $4M | $2M | $4M | $1M | $721.0K | $2M | $4M | $5M | $6M | $4M | $5M | |
| Capital Leases | $0 | $421.0K | $888.0K | $1M | $2M | $0 | · | $0 | · | · | · | $0 | |
| Total Liabilities | $8M | $4M | $3M | $5M | $3M | $721.0K | $2M | $4M | $5M | $7M | $5M | $5M | |
| Common Stock | $3.0K | $2.0K | $1.0K | $9.0K | $9.0K | $9.0K | $7.0K | $124.0K | $111.0K | $104.0K | $92.0K | $82.0K | |
| Retained Earnings | $-356M | $-342M | $-340M | $-325M | $-308M | $-296M | $-279M | $-261M | $-234M | $-199M | $-161M | $-122M | |
| Treasury Stock | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | · | · | · | · | · | |
| AOCI | · | · | $0 | $2.0K | $0 | · | · | · | $0 | $-11.0K | $0 | · | |
| Stockholders' Equity | $-1M | $10M | $4M | $15M | $30M | $39M | $27M | $36M | $45M | $62M | $62M | $49M | |
| Liabilities + Equity | $7M | $15M | $6M | $20M | $33M | $40M | $28M | $41M | $50M | $69M | $68M | $53M | |
| Shares Outstanding | 2,894,519 | 1,898,068 | 839,814 | 8,716,906 | 8,710,627 | 8,670,492 | 6,527,905 | 124,015,429 | 111,032,957 | 104,551,466 | 104,551,466 | 81,536,724 |
Nakit Akışı
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $215.0K | $266.0K | $280.0K | $293.0K | $142.0K | $41.0K | $1M | $980.0K | $1M | $1M | $815.0K | $472.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | $7M | $7M | $9M | $7M | |
| Other Non-cash | $3M | · | · | · | $3M | · | · | $5M | $-2M | $721.0K | $-164.0K | $3M | |
| Operating Cash Flow | $-11M | $-9M | $-15M | $-12M | $-8M | $-13M | $-15M | $-20M | $-29M | $-29M | $-29M | $-20M | |
| CapEx | $0 | $13.0K | $42.0K | $396.0K | $409.0K | $405.0K | $0 | $79.0K | $226.0K | $1M | $2M | $2M | |
| Investing Cash Flow | $94.0K | $9M | $816.0K | $-966.0K | $-409.0K | $-393.0K | $747.0K | $-76.0K | $-292.0K | · | · | · | |
| Stock Issued | $5M | $9M | $1M | $0 | $251.0K | $24M | $5M | $13M | $9M | · | · | · | |
| Stock Repurchased | · | · | · | · | $0 | $1.0K | $0 | · | · | · | · | · | |
| Net Stock Activity | $5M | · | · | · | $251.0K | · | · | $13M | · | · | · | · | |
| Financing Cash Flow | $4M | $9M | $1M | $0 | $205.0K | $24M | $5M | $13M | $10M | · | · | · | |
| Net Change in Cash | $-6M | $8M | $-12M | $-13M | $-9M | $10M | $-9M | $-7M | $-19M | $660.0K | $12M | $2M | |
| Free Cash Flow | $-11M | · | · | · | $-9M | · | · | $-20M | $-29M | $-31M | $-31M | $-21M |
Kârlılık
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8768.7% | · | · | · | -765.3% | · | · | -882.4% | -766.3% | -911.9% | -2605.7% | -5305.9% | |
| Net Margin | -10567.2% | · | · | · | -763.2% | · | · | -861.7% | -756.1% | -908.9% | -2601.2% | -5268.3% | |
| Pretax Margin | -10565.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -8604.6% | · | · | · | -755.8% | · | · | -850.7% | -738.7% | -884.8% | -2550.8% | -5223.3% | |
| ROA | -125.6% | · | · | · | -31.3% | · | · | -58.9% | -58.5% | -56.2% | -63.7% | -58.0% | |
| ROE | -294.8% | · | · | · | -33.0% | · | · | -65.9% | -65.1% | -61.7% | -69.6% | -62.0% | |
| ROIC | 1045.4% | · | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | · | · | · | 21.4 | · | · | 10.3 | 10.0 | 10.8 | 14.2 | 10.8 | |
| Quick Ratio | 1.8 | · | · | · | 20.7 | · | · | 9.9 | 9.6 | 10.5 | 13.9 | 10.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -30297.0 |
Verimlilik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | 0.0 | · | · | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.7 | 1.5 | 2.2 | · | · | |
| Receivables Turnover | 4.2 | · | · | · | · | · | · | 4.5 | 6.0 | 9.3 | 11.5 | · |
Hisse Başına
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.38 | · | · | · | $3.47 | · | · | $0.29 | $0.40 | $0.60 | $0.67 | $0.60 | |
| Revenue / Share | $0.05 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-4.18 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.74 | · | · | · | $3.29 | · | · | $0.29 | $0.39 | $0.60 | $0.67 | $0.61 | |
| EPS (TTM) | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 | $1.24 | $1.24 | $1.24 | $1.24 | $1.24 | $1.24 | $1.24 |
Büyüme Oranları
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -9.0% | 32.1% | -70.5% | -75.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -29.3% | -54.2% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $131.0K | $144.0K | $109.0K | $370.0K | $2M | $0 | $2M | $3M | $5M | $4M | $1M | $571.0K | |
| Net Income TTM | $-14M | $-2M | $-15M | $-17M | $-11M | $-17M | $-19M | $-27M | $-35M | $-38M | $-39M | $-30M | |
| Market Cap | $4M | · | · | · | $393M | · | · | $29.47B | $27.45B | $79.79B | $48.12B | $69.27B | |
| P/E | -0.3 | -1.3 | -0.6 | -13.3 | -34.2 | 93.3 | 79.4 | 191.6 | 199.4 | 615.5 | 420.0 | 685.2 | |
| P/S | 31.6 | · | · | · | 262.0 | · | · | 9532.9 | 5962.9 | 18863.8 | 32446.2 | 121319.8 | |
| P/B | -3.8 | · | · | · | 13.0 | · | · | 811.8 | 615.6 | 1279.5 | 773.8 | 1422.6 | |
| P / Tangible Book | · | 0.4 | 34.6 | 14.9 | 13.0 | 25.6 | · | · | · | · | · | · | |
| P / Cash Flow | -0.4 | · | · | · | -46.5 | · | · | -1446.2 | -951.2 | -2734.1 | -1638.4 | -3534.2 | |
| P / FCF | -0.4 | · | · | · | -44.3 | · | · | -1440.6 | -943.8 | -2612.8 | -1528.4 | -3280.3 | |
| Earnings Yield | -374.1% | -75.9% | -155.7% | -7.5% | -2.9% | 1.1% | 1.3% | 0.52% | 0.50% | 0.16% | 0.24% | 0.15% |
Gelir Tablosu
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.0K | $40.0K | $26.0K | $28.0K | $37.0K | $51.0K | $24.0K | $30.0K | $39.0K | $29.0K | $5.0K | $0 | $75.0K | $162.0K | $131.0K | $77.0K | |
| Cost of Revenue | · | $0 | $0 | $0 | $0 | $0 | $2.0K | $1.0K | $2.0K | · | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $1M | $1M | $1M | $923.0K | $1M | $859.0K | $2M | $984.0K | $1M | $1M | $1M | $1M | $2M | $5M | $1M | $1M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | |
| Operating Expenses | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $8M | $3M | $3M | |
| Operating Income | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-4M | $-4M | $-8M | $-3M | $-3M | |
| Interest Income | $28.0K | $36.0K | $63.0K | $92.0K | $76.0K | $11.0K | $26.0K | $59.0K | $44.0K | $51.0K | $76.0K | $121.0K | $157.0K | $177.0K | $143.0K | $103.0K | |
| Other Non-op | $1M | $-3M | $59.0K | $92.0K | $72.0K | $10M | $21.0K | $59.0K | $44.0K | $51.0K | $76.0K | $121.0K | $169.0K | $320.0K | $95.0K | $33.0K | |
| Income Tax | $3.0K | $0 | $0 | $2.0K | $0 | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | |
| Net Income | $-1M | $-6M | $-3M | $-3M | $-3M | $7M | $-3M | $-3M | $-3M | $-3M | $-4M | $-4M | $-4M | $-7M | $-3M | $-3M | |
| EPS (Basic) | $-0.25 | $-2.20 | $-1.03 | $-0.98 | $-1.14 | $5.00 | $-2.28 | $-1.68 | $-2.74 | $-17.93 | $-0.40 | $-0.46 | $-0.46 | $-0.86 | $-0.37 | $-0.38 | |
| EPS (Diluted) | $-0.25 | $-2.20 | $-1.03 | $-0.98 | $-1.14 | $5.00 | $-2.28 | $-1.68 | $-2.74 | $-17.93 | $-0.40 | $-0.46 | $-0.46 | $-0.86 | $-0.37 | $-0.38 | |
| Shares (Basic) | 5,239,462 | · | 2,607,962 | 2,604,950 | 2,503,697 | · | 1,504,713 | 1,499,544 | 1,221,974 | · | 9,115,455 | 8,718,502 | 8,717,232 | · | 8,713,617 | 8,712,284 | |
| Shares (Diluted) | 5,239,462 | · | 2,607,962 | 2,604,950 | 2,503,697 | · | 1,504,713 | 1,499,544 | 1,221,974 | · | 9,115,455 | 8,718,502 | 8,717,232 | · | 8,713,617 | 8,712,284 | |
| EBITDA | $-3M | · | $-3M | $-3M | $-3M | · | $-3M | $-3M | $-3M | · | $-4M | $-4M | $-4M | · | $-3M | $-3M |
Bilanço
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $4M | $7M | $9M | $11M | $1M | $3M | $6M | $3M | $5M | $8M | $11M | $15M | $20M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| Receivables | $29.0K | $32.0K | $33.0K | $32.0K | $32.0K | $30.0K | $26.0K | $29.0K | $48.0K | $33.0K | $33.0K | $55.0K | $149.0K | $152.0K | $76.0K | · | |
| Inventory | · | · | · | · | · | $0 | $0 | $640.0K | $408.0K | $297.0K | · | · | · | $0 | · | · | |
| Prepaid Expense | $511.0K | $557.0K | $709.0K | $882.0K | $592.0K | $789.0K | $913.0K | $940.0K | $640.0K | $705.0K | $913.0K | $624.0K | $792.0K | $889.0K | $788.0K | $519.0K | |
| Other Current Assets | · | $0 | · | · | · | $12.0K | · | · | · | $4.0K | · | · | · | $69.0K | · | · | |
| Current Assets | $3M | $7M | $6M | $8M | $10M | $12M | $2M | $5M | $7M | $4M | $6M | $8M | $12M | $17M | $22M | $24M | |
| PP&E (Net) | $189.0K | $206.0K | $248.0K | $300.0K | $359.0K | $419.0K | $479.0K | $545.0K | $601.0K | $669.0K | $739.0K | $808.0K | $850.0K | $902.0K | $742.0K | $758.0K | |
| PP&E (Gross) | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | |
| Accum. Depreciation | · | $2M | · | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Total Assets | $4M | $7M | $7M | $10M | $12M | $15M | $4M | $7M | $9M | $6M | $9M | $11M | $15M | $20M | $25M | $28M | |
| Accounts Payable | $621.0K | $1M | $671.0K | $580.0K | $673.0K | $2M | $930.0K | $419.0K | $1M | $627.0K | $471.0K | $435.0K | $488.0K | $331.0K | $242.0K | $441.0K | |
| Accrued Liabilities | $738.0K | $981.0K | $818.0K | $771.0K | $727.0K | $1M | $1M | $879.0K | $404.0K | $727.0K | $727.0K | $666.0K | $787.0K | $3M | $646.0K | $462.0K | |
| Current Liabilities | $2M | $3M | $2M | $2M | $2M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $1M | $1M | |
| Capital Leases | $0 | $0 | $44.0K | $172.0K | $298.0K | $421.0K | $543.0K | $660.0K | $775.0K | $888.0K | $999.0K | $1M | $1M | $1M | $1M | $2M | |
| Total Liabilities | $6M | $8M | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $3M | $3M | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $17.0K | $15.0K | $14.0K | $1.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | |
| Retained Earnings | $-357M | $-356M | $-350M | $-348M | $-345M | $-342M | $-349M | $-346M | $-343M | $-340M | $-337M | $-333M | $-329M | $-325M | $-318M | $-314M | |
| Treasury Stock | · | $0 | $0 | $0 | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| AOCI | · | · | · | · | · | · | · | $1.0K | · | · | $1.0K | $1.0K | $2.0K | $2.0K | $3.0K | · | |
| Stockholders' Equity | $-2M | $-1M | $4M | $7M | $10M | $10M | $364.0K | $4M | $7M | $4M | $6M | $8M | $12M | $15M | $22M | $25M | |
| Liabilities + Equity | $4M | $7M | $7M | $10M | $12M | $15M | $4M | $7M | $9M | $6M | $9M | $11M | $15M | $20M | $25M | $28M | |
| Shares Outstanding | 3,194,295 | 2,894,519 | 2,607,962 | 2,607,962 | 2,599,797 | 1,898,068 | 17,133,346 | 15,365,825 | 14,373,076 | 839,814 | 9,838,755 | 8,719,453 | 8,718,203 | 8,716,906 | 8,714,590 | 8,713,268 |
Nakit Akışı
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40.0K | $43.0K | $52.0K | $59.0K | $61.0K | $61.0K | $67.0K | $68.0K | $70.0K | $71.0K | $71.0K | $71.0K | $67.0K | $59.0K | $130.0K | $54.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | |
| Other Non-cash | $-2M | · | · | · | $-1M | · | · | · | $291.0K | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-2M | $-4M | $-2M | $-2M | $-3M | $-3M | $-3M | $-4M | $-3M | $-5M | $-5M | $-3M | $-2M | |
| CapEx | $23.0K | $0 | $0 | $0 | $0 | $0 | $0 | $13.0K | $0 | $0 | $0 | $27.0K | $15.0K | $162.0K | $41.0K | $119.0K | |
| Investing Cash Flow | $-23.0K | $94.0K | $0 | $0 | $0 | $9M | $4.0K | $0 | $20.0K | $13.0K | $27.0K | $12.0K | $764.0K | $-162.0K | $10M | $-86.0K | |
| Stock Issued | $0 | $3M | $0 | $0 | $2M | $3M | $-216.0K | $-371.0K | $6M | $264.0K | $1M | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | $0 | · | · | · | $2M | · | · | · | $6M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-118.0K | $3M | $-118.0K | $0 | $2M | $3M | $-216.0K | $-371.0K | $6M | $264.0K | $1M | $0 | $0 | $0 | $0 | $0 | |
| Net Change in Cash | $-3M | $736.0K | $-2M | $-2M | $-2M | $10M | $-2M | $-3M | $3M | $-2M | $-2M | $-3M | $-5M | $-5M | $7M | $-2M | |
| Free Cash Flow | $-3M | · | · | · | · | · | · | · | $-3M | · | · | · | $-5M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -15327.8% | · | -10576.9% | -9410.7% | -7878.4% | · | -14450.0% | -8693.3% | -8682.0% | · | -73600.0% | · | -5593.3% | · | -2564.1% | -4355.8% | |
| Net Margin | -7433.3% | · | -10350.0% | -9089.3% | -7683.8% | · | -14362.5% | -8496.7% | -8574.4% | · | -72080.0% | · | -5370.7% | · | -2491.6% | -4313.0% | |
| EBITDA Margin | -15105.6% | · | -10576.9% | -9410.7% | -7713.5% | · | -14450.0% | -8693.3% | -8502.6% | · | -73600.0% | · | -5504.0% | · | -2564.1% | -4355.8% | |
| ROA | -16.9% | · | -49.8% | -31.0% | -26.5% | · | -54.2% | -28.5% | -27.6% | · | -21.2% | -20.4% | -17.8% | · | -10.8% | -10.4% | |
| ROE | -37.2% | · | -112.0% | -47.4% | -35.1% | · | -105.3% | -42.0% | -36.3% | · | -25.3% | -23.9% | -20.4% | · | -12.2% | -11.2% |
Likidite ve Solventlik
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | · | 2.4 | 3.1 | 4.5 | · | 0.7 | 2.0 | 3.6 | · | 3.7 | 5.2 | 6.6 | · | 15.7 | 17.5 | |
| Quick Ratio | 0.9 | · | 1.7 | 2.7 | 4.2 | · | 0.4 | 1.3 | 3.1 | · | 3.1 | 4.8 | 6.2 | · | 14.7 | 16.7 |
Verimlilik
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.6 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.7 | 0.4 | · | 0.1 | 0.0 | 0.6 | · | 3.4 | · |
Hisse Başına
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.73 | · | $1.70 | $2.71 | $3.67 | · | $0.02 | $0.24 | $0.46 | · | $0.63 | $0.97 | $1.35 | · | $2.56 | $2.87 | |
| Revenue / Share | $0.00 | · | $0.01 | $0.01 | $0.01 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.01 | · | $0.01 | $0.01 | |
| Cash Flow / Share | $-0.61 | · | · | · | $-1.57 | · | · | · | $-0.20 | · | · | · | $-0.61 | · | · | · | |
| Cash / Share | $0.52 | · | $1.64 | $2.56 | $3.48 | · | $0.07 | $0.21 | $0.43 | · | $0.54 | $0.87 | $1.23 | · | $2.32 | $1.52 | |
| EPS (TTM) | $-4.46 | · | $1.85 | $0.60 | $-0.10 | · | $-24.63 | $-22.75 | $-21.53 | · | $-2.18 | $-2.15 | $-2.07 | · | $-1.35 | $-1.38 |
Değerleme (TTM)
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112.0K | · | $142.0K | $140.0K | $142.0K | · | $122.0K | $103.0K | $73.0K | · | $242.0K | $368.0K | $445.0K | · | $2M | $2M | |
| Net Income TTM | $-12M | · | $-1M | $-2M | $-2M | · | $-12M | $-13M | $-14M | · | $-19M | $-19M | $-18M | · | $-12M | $-12M | |
| Market Cap | $3M | · | $5M | $8M | $4M | · | $95M | $94M | $131M | · | $131M | $131M | $177M | · | $147M | $214M | |
| P/E | -0.2 | · | 1.0 | 4.9 | -14.7 | · | -0.2 | -0.3 | -0.4 | · | -6.1 | -7.0 | -9.8 | · | -12.5 | -17.8 | |
| P/S | 30.5 | · | 33.2 | 54.4 | 26.9 | · | 775.2 | 913.0 | 1795.7 | · | 541.5 | 355.4 | 397.3 | · | 86.3 | 135.9 | |
| P/B | -1.5 | · | 1.1 | 1.1 | 0.4 | · | 259.8 | 25.6 | 19.7 | · | 21.2 | 15.5 | 15.0 | · | 6.6 | 8.6 | |
| P / Tangible Book | · | · | 1.1 | 1.1 | 0.4 | · | 259.8 | 25.6 | 19.7 | · | 21.2 | 15.5 | 15.0 | · | 6.6 | 8.6 | |
| P / Cash Flow | -1.1 | · | · | · | -1.0 | · | · | · | -43.9 | · | · | · | -33.3 | · | · | · | |
| Earnings Yield | -416.8% | · | 102.2% | 20.5% | -6.8% | · | -446.2% | -371.7% | -236.1% | · | -16.4% | -14.3% | -10.2% | · | -8.0% | -5.6% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Gelir | $131.0K | $144.0K | $109.0K | $370.0K | $2M |
| Faaliyet Kâr Marjı % | -8768.7% | · | · | · | -765.3% |
| Net Gelir | $-14M | $-2M | $-15M | $-17M | $-11M |
| Seyreltilmiş Hisse Başı Kâr | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Cari Oran | 2.4 | · | · | · | 21.4 |
| Cari Oran | 1.8 | · | · | · | 20.7 |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-11M | · | · | · | $-9M |
Kurumsal Sahipler (13F) 26 dosya · $131K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
26
Tutulan Değer
$131K
Yeni pozisyonlar
4
Çıkan pozisyonlar
3
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 4 (-1 önceki Ç'ye göre) | 3 (-4 önceki Ç'ye göre) | 2 (-2 önceki Ç'ye göre) | 5 (+3 önceki Ç'ye göre) | +5K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $40.497 | 22.374 | 30,86% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $27.795 | 25.976 | 21,18% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $19.795 | 18.500 | 15,09% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.447 | 15.371 | 12,53% | Hisse senetleri |
| BlackRock, Inc. | $12.644 | 11.817 | 9,64% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $7.493 | 7.003 | 5,71% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $5.616 | 5.249 | 4,28% | Hisse senetleri |
| SBI Securities Co., Ltd. | $236 | 221 | 0,18% | Hisse senetleri |
| Larson Financial Group LLC | $178 | 166 | 0,14% | Hisse senetleri |
| ALBION FINANCIAL GROUP /UT | $171 | 159 | 0,13% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $119 | 111 | 0,09% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $88 | 84 | 0,07% | Hisse senetleri |
| MORGAN STANLEY | $52 | 49 | 0,04% | Hisse senetleri |
| UBS Group AG | $20 | 18 | 0,02% | Hisse senetleri |
| HRT FINANCIAL LP | $19 | 18.319 | 0,01% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $18 | 17 | 0,01% | Hisse senetleri |
| IFG Advisory, LLC | $15 | 14 | 0,01% | Hisse senetleri |
| Rockefeller Capital Management L.P. | $2 | 2 | 0,00% | Hisse senetleri |
| Golden State Wealth Management, LLC | $2 | 2 | 0,00% | Hisse senetleri |
| Federation des caisses Desjardins du Quebec | $2 | 2 | 0,00% | Hisse senetleri |
| Activest Wealth Management | $2 | 2 | 0,00% | Hisse senetleri |
| HARBOUR INVESTMENTS, INC. | $1 | 1 | 0,00% | Hisse senetleri |
| First Command Advisory Services, Inc. | $1 | 1 | 0,00% | Hisse senetleri |
| Hilton Head Capital Partners, LLC | $1 | 1 | 0,00% | Hisse senetleri |
| FNY Investment Advisers, LLC | $0 | 200 | 0,00% | Hisse senetleri |
| ROYAL BANK OF CANADA | $0 | 1 | 0,00% | Hisse senetleri |
Şirket yöneticileri 31 içeriden öğrenenler · 14 yöneticiler · 17 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Taylor Crouch | CEO & President | 18 Ağustos 2020 F | 125.144 | 0 | 0 | $0 |
| Craig Kussman | Chief Financial Officer | 18 Ağustos 2020 F | 221.743 | 0 | 0 | $0 |
| Barry D Michaels | Chief Financial Officer | 24 Ağustos 2015 A | 86.808 | 0 | 0 | $0 |
| Tony Serge Lialin | Chief Commercial Officer | 31 Ağustos 2026 P | 10.000 | 1 | 0 | $2.800 |
| Murphy Keith | EXECUTIVE CHAIRMAN | 27 Ocak 2026 A | 26.053 | 0 | 0 | $0 |
| Amar Akhtar Sethi | Chief Scientific Officer | 25 Kasım 2025 A | · | 0 | 0 | $0 |
| Jeffrey N. Miner | Chief Scientific Officer | 31 Ağustos 2022 A | · | 0 | 0 | $0 |
| Thomas E Jurgensen | General Counsel & Secretary | 31 Ağustos 2022 A | · | 0 | 0 | $0 |
| Jennifer Bush | General Counsel & Secretary | 18 Ağustos 2020 F | 192.758 | 0 | 0 | $0 |
| Steven George Hughes | Chief Medical Officer | 16 Ağustos 2019 S | 138.484 | 0 | 0 | $0 |
| Paul Gallant | General Manager | 16 Ağustos 2019 F | 191.335 | 0 | 0 | $0 |
| Sharon Collins Presnell | Chief Scientific Officer | 16 Kasım 2018 F | 280.993 | 0 | 0 | $0 |
| Eric David | CSO & EVP Pre-Clinical Dev | 16 Kasım 2017 F | 876.609 | 0 | 0 | $0 |
| Michael Renard | EVP of Commercial Operations | 04 Haziran 2015 A | 50.000 | 0 | 0 | $0 |
| David Gobel | Yönetim kurulu üyesi | 27 Ocak 2026 A | 15.000 | 0 | 1 | $-7.316 |
| Alison Tjosvold Milhous | Yönetim kurulu üyesi | 27 Ocak 2026 A | 19.899 | 0 | 0 | $0 |
| Douglas Jay Cohen | Yönetim kurulu üyesi | 27 Ocak 2026 A | 20.732 | 0 | 0 | $0 |
| Adam K Stern | Yönetim kurulu üyesi | 27 Ocak 2026 A | 19.899 | 0 | 0 | $0 |
| Vaidehi Joshi | Yönetim kurulu üyesi | 07 Ağustos 2024 A | 58.821 | 0 | 0 | $0 |
| David Shapiro | Yönetim kurulu üyesi | 05 Eylül 2019 A | · | 0 | 0 | $0 |
| Richard E Maroun | Yönetim kurulu üyesi | 05 Eylül 2019 A | 15.000 | 0 | 0 | $0 |
| Carolyn Beaver | Yönetim kurulu üyesi | 05 Eylül 2019 A | · | 0 | 0 | $0 |
| Kirk Malloy | Yönetim kurulu üyesi | 05 Eylül 2019 A | 7.500 | 0 | 0 | $0 |
| Mark Kessel | Yönetim kurulu üyesi | 05 Eylül 2019 A | 15.000 | 0 | 0 | $0 |
| Robert Baltera Jr. | Yönetim kurulu üyesi | 26 Temmuz 2018 A | 146.006 | 0 | 0 | $0 |
| James T Glover | Yönetim kurulu üyesi | 26 Temmuz 2018 A | 17.500 | 0 | 0 | $0 |
| Tamar D Howson | Yönetim kurulu üyesi | 26 Temmuz 2018 A | 7.500 | 0 | 0 | $0 |
| Richard A. Heyman | Yönetim kurulu üyesi | 20 Ağustos 2015 A | · | 0 | 0 | $0 |
| Andras Forgacs | Yönetim kurulu üyesi | 18 Ekim 2012 A | · | 0 | 0 | $0 |
| Chris Heberlig | · | 15 Eylül 2020 A | · | 0 | 0 | $0 |
| Kevin Kimberlin | · | 27 Eylül 2012 J | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 15.371 SH | 19 Ağustos 2026 | Günlük |
VIVS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
SAT
0 0,0%
Güçlü Al
0 0,0%
Al
4 57,1%
Tut
1 14,3%
Sat
2 28,6%
Güçlü Sat
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| VIVS | $4M | -0.3 | -9.0% | -10567.2% | -294.8% | · |
| HCWB | · | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| MBIO | · | -2.5 | · | · | -30.9% | · |
| DCOY | · | -0.0 | · | · | · | · |
| GOVX | $296.2K | · | -37.1% | -862.3% | -645.9% | · |
| ONCO | $2M | -0.1 | -67.7% | -1721.0% | -129.5% | 77.6% |
| ADTX | $343.6K | -0.0 | -97.6% | -1349028.2% | -1183.4% | 8.4% |
| APVO | $9M | -0.1 | · | · | -217.2% | · |
| REVB | · | · | · | · | · | · |
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 12, 2026